MGC Pharmaceuticals Ltd: Change of Director's Interest Notice - LM
MGC Pharmaceuticals Ltd: Change of Director's Interest Notice - DR
MGC Pharmaceuticals Ltd: Refinancing of Convertible Security Agreement
MGC Pharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
MGC Pharmaceuticals Ltd: Pause in trading
MGC Pharmaceuticals Ltd: ArtemiC Receives FDA Approval in Saudi Arabia
MGC Pharmaceuticals Ltd: Initial Director's Interest Notice
MGC Pharmaceuticals Ltd: Final Director's Interest Notice x 2
MGC Pharmaceuticals Ltd: Trading Halt
MGC Pharmaceuticals Ltd: Annual General Meeting Update
MGC Pharmaceuticals Ltd: Appendix 4G and Corporate Governance Statement
MGC Pharmaceuticals Ltd: Change of Share Registry Address
MGC Pharmaceuticals Ltd: Pre-clinical Trial Results on CimetrA
MGC Pharmaceuticals Ltd: Company Update
MGC Pharmaceuticals Ltd: MGC receives permission for first import of Psilocybin
MGC Pharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
MGC Pharmaceuticals Ltd: Clarification Announcement
MGC Pharmaceuticals Ltd: AMC Places Second Order of ArtemiC for US$1M
MGC Pharmaceuticals Ltd: MGC Welcomes Reclassification of Psychedelic Compounds
MGC Pharmaceuticals Ltd: Details of Company Address
No Data